[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100501412":3},{"organization":4,"outcomesModule":7,"designInfo":67,"detailedDescription":69,"studyPopulation":70,"armGroups":71,"interventions":77,"overallOfficials":83,"centralContacts":88,"locations":98,"responsibleParty":208,"collaborators":66,"id":210,"slug":66,"hasResults":211,"nctId":212,"briefTitle":213,"officialTitle":213,"acronym":214,"eligibilityCriteria":215,"healthyVolunteers":211,"sex":216,"minAge":217,"maxAge":66,"enrollmentInfo":218,"targetDuration":66,"studyType":221,"phases":66,"briefSummary":222,"conditions":223,"keywords":66,"overallStatus":101,"whyStopped":66,"lastUpdateSubmitDate":225,"lastUpdatePostDateStruct":226,"startDateStruct":229,"completionDateStruct":231,"leadSponsor":233,"locationsCount":234},{"fullName":5,"class":6},"Royal Marsden NHS Foundation Trust","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":66},[9],{"measure":10,"description":11,"timeFrame":12},"Ascertain the 2-year disease-free survival post salvage surgery","Ascertain the 2-year disease-free survival post salvage surgery for recurrent\u002F residual\u002F new primary head and neck SCC (split cohort of prospective and retrospective patients)","Study duration is 3 years to include 1 year recruitment period. Active follow-up for patients is up to 2 years.",[14,18,21,24,28,32,35,37,39,41,43,45,47,49,51,53,55,57,60,63],{"measure":15,"description":16,"timeFrame":17},"Define the 2- and 5-year overall and disease specific survival in retrospectively identified patients","Define the 2- and 5-year overall and disease specific survival in retrospectively identified patients undergoing salvage surgery for recurrent\u002F residual\u002F new primary head and neck SCC","Study duration is 3 years to include 1 year recruitment period. Active follow-up for prospective patients is up to 2 years. Follow-up for retrospective patients is up to 5 years.",{"measure":19,"description":20,"timeFrame":12},"Define the 2 year overall and disease specific survival in prospectively identified patients","Define the 2 year overall and disease specific survival in prospectively identified patients undergoing salvage surgery for recurrent\u002F residual\u002F new primary head and neck SCC",{"measure":22,"description":22,"timeFrame":23},"Report on gross functional outcomes by documenting rates of gastrostomy and tracheostomy dependence at 1-year post-salvage surgery.","Study duration is 3 years with up to 2 years follow-up in prospective and up to 5 years follow-up in retrospective patients. Functional outcomes will be measured from the date of surgery.",{"measure":25,"description":26,"timeFrame":27},"For the prospective cohort assess the overall quality-of-life outcomes pre-operatively and at 6- and 12-months post-surgery using validated questionnaires.","For the prospective cohort assess the overall quality-of-life outcomes at pre-operatively and at 6- and 12-months post-surgery using validated University of Washington Quality of Life questionnaire.","University of Washing Quality of life questionnaire distributed pre-operatively, 6 months and 12 months.",{"measure":29,"description":30,"timeFrame":31},"For the prospective cohort assess the swallow-related quality-of-life outcomes at pre-operatively and at 6- and 12-months post-surgery using validated questionnaires.","For the prospective cohort assess the swallow-related quality-of-life outcomes pre-operatively and at 6- and 12-months post-surgery using validated questionnaires.","MD Anderson Dysphagia Inventory distributed pre-operatively, 6 months and 12 months.",{"measure":33,"description":33,"timeFrame":34},"Estimate the rates of close and involved surgical margins across all surgical salvage procedures","Through study completion, expected duration of 3 years",{"measure":36,"description":36,"timeFrame":34},"Determine the impact of close and involved margins on overall survival outcomes",{"measure":38,"description":38,"timeFrame":34},"Determine the impact of close and involved margins on disease-free survival outcomes",{"measure":40,"description":40,"timeFrame":34},"Determine the impact of close and involved margins on disease-specific survival outcomes",{"measure":42,"description":42,"timeFrame":34},"Establish the rates of super-selective, selective and modified\u002F radical salvage neck dissection in clinically N0 and N+ necks",{"measure":44,"description":44,"timeFrame":34},"Ascertain how the extent of salvage neck dissection influences overall survival outcomes.",{"measure":46,"description":46,"timeFrame":34},"Ascertain how the extent of salvage neck dissection influences disease-free survival outcomes.",{"measure":48,"description":48,"timeFrame":34},"Ascertain how the extent of salvage neck dissection influences disease-specific survival outcomes.",{"measure":50,"description":50,"timeFrame":34},"Estimate the rate of occult nodal metastasis in clinically N0 necks with locally recurrent disease",{"measure":52,"description":52,"timeFrame":34},"Describe the impact of neck dissection on overall survival outcomes in patients with clinically N0 necks with and without subsequent occult nodal disease",{"measure":54,"description":54,"timeFrame":34},"Describe the impact of neck dissection on disease-free survival outcomes in patients with clinically N0 necks with and without subsequent occult nodal disease",{"measure":56,"description":56,"timeFrame":34},"Describe the impact of neck dissection on disease-specific survival outcomes in patients with clinically N0 necks with and without subsequent occult nodal disease",{"measure":58,"description":59,"timeFrame":34},"Using multi-variate analysis, establish the clinical prognostic indicators of overall, disease free and disease specific survival.","Establish the clinical prognostic indicators of positive survival and functional outcomes",{"measure":61,"description":62,"timeFrame":34},"Using multi-variate analysis, establish the clinical prognostic indicators 12 month tracheostomy and gastrostomy dependence.","Establish the clinical prognostic indicators of functional outcomes",{"measure":64,"description":65,"timeFrame":34},"Compare the DNA genetic and epigenetic changes in residual, recurrent, and new primary head and neck squamous cell carcinoma with primary tumour and germline DNA samples.","Assess the molecular makeup of head and neck tumours that have not responded to radiotherapy treatment, or which recur having previously responded.",null,{"allocation":66,"interventionModel":66,"interventionModelDescription":66,"primaryPurpose":66,"observationalModel":68,"timePerspective":6,"maskingInfo":66},"COHORT","The RESCUE study is a combined retrospective and prospective multicentre cohort study investigating the survival and functional outcomes in patients undergoing salvage surgery for recurrent, residual, and new primary head and neck squamous cell carcinoma (SCC).\n\nAdditionally, the RESCUE study will contain an exploratory molecular analysis of consenting patients to assess the relationship between cancer genomics, previous radiotherapy, and recurrence in head and neck cancer.\n\nThe aim of this study is to determine the survival, functional and quality of life outcomes of patients undergoing all salvage surgery for recurrent, residual and new primary head and neck SCC, and to establish the genetic architecture and clonal evolution H\\&N SCC after previous treatment for radiotherapy cancer.","Patients diagnosed with recurrent, residual or new primary head and neck SCC following previous treatment with radiotherapy with or without chemotherapy who have undergone or will undergo salvage surgical resection of their cancer. Head and neck subsites including the oropharynx, oral cavity, larynx and hypopharynx will be included. H\\&N SCC of nasopharyngeal and cutaneous origins, non-SCC, thyroid and salivary gland tumours of the head and neck will be excluded.",[72],{"label":73,"type":66,"description":74,"interventionNames":75},"Group 1","Participants with previous diagnosis of H\\&N SCC treated with radiotherapy. Recurrent, residual, or new primary SCC of the oropharynx, oral cavity, larynx, and hypopharynx treated with salvage surgery",[76],"Genetic: Molecular Analyses",[78],{"type":79,"name":80,"description":81,"armGroupLabels":82,"otherNames":66},"GENETIC","Molecular Analyses","Nucleic acid extraction, protein analysis. Tumour tissue, blood and saliva samples collected.",[73],[84],{"name":85,"affiliation":86,"role":87},"Vinidh Paleri","Royal Marsden Hospital NHS Foundation Trust","PRINCIPAL_INVESTIGATOR",[89,95],{"name":90,"role":91,"phone":92,"phoneExt":93,"email":94},"Andrew Williamson","CONTACT","02073528171","1876","andrew.williamson2@rmh.nhs.uk",{"name":96,"role":91,"phone":92,"phoneExt":93,"email":97},"Sarah Burton","RESCUE@rmh.nhs.uk",[99,116,128,140,153,166,175,187,199],{"facility":100,"status":101,"city":102,"state":66,"zip":66,"country":103,"countryCode":104,"cosmosGeoPoint":105,"geoPoint":110,"contacts":111},"University Hospitals Derby and Burton","RECRUITING","Derby","United Kingdom","UK",{"type":106,"coordinates":107},"Point",[108,109],-1.47663,52.92277,{"lat":109,"lon":108},[112],{"name":113,"role":91,"phone":114,"phoneExt":66,"email":115},"Sean Mortimore","0000","uhdb.radiotherapytrials@nhs.net",{"facility":117,"status":101,"city":118,"state":66,"zip":66,"country":103,"countryCode":104,"cosmosGeoPoint":119,"geoPoint":123,"contacts":124},"NHS Lothian","Edinburgh",{"type":106,"coordinates":120},[121,122],-3.19648,55.95206,{"lat":122,"lon":121},[125],{"name":126,"role":91,"phone":114,"phoneExt":66,"email":127},"Iain Nixon","iain.nixon@nhs.scot",{"facility":129,"status":101,"city":130,"state":66,"zip":66,"country":103,"countryCode":104,"cosmosGeoPoint":131,"geoPoint":135,"contacts":136},"Western General, Greater Glasgow and Clyde","Glasgow",{"type":106,"coordinates":132},[133,134],-4.25763,55.86515,{"lat":134,"lon":133},[137],{"name":138,"role":91,"phone":114,"phoneExt":66,"email":139},"Catriona Douglas","catriona.douglas@ggc.scot.nhs.uk",{"facility":141,"status":101,"city":142,"state":66,"zip":66,"country":103,"countryCode":104,"cosmosGeoPoint":143,"geoPoint":147,"contacts":148},"Aintree Hospital","Liverpool",{"type":106,"coordinates":144},[145,146],-2.97794,53.41058,{"lat":146,"lon":145},[149],{"name":150,"role":91,"phone":151,"phoneExt":66,"email":152},"Terry Jones","00000","terry.jones@liverpoolft.nhs.uk",{"facility":154,"status":101,"city":155,"state":66,"zip":156,"country":103,"countryCode":104,"cosmosGeoPoint":157,"geoPoint":161,"contacts":162},"Head and Neck Unit, Royal Marsden Hospital","London","SW3 6JJ",{"type":106,"coordinates":158},[159,160],-0.12574,51.50853,{"lat":160,"lon":159},[163],{"name":164,"role":91,"phone":66,"phoneExt":66,"email":165},"Vishak Muraleedharan Shylaja","vishak.muraleedharanshylaja@rmh.nhs.uk",{"facility":167,"status":101,"city":155,"state":66,"zip":66,"country":103,"countryCode":104,"cosmosGeoPoint":168,"geoPoint":170,"contacts":171},"Northwick Park",{"type":106,"coordinates":169},[159,160],{"lat":160,"lon":159},[172],{"name":173,"role":91,"phone":114,"phoneExt":66,"email":174},"Swati Chhabra","swati.chhabra@nhs.net",{"facility":176,"status":101,"city":177,"state":66,"zip":66,"country":103,"countryCode":104,"cosmosGeoPoint":178,"geoPoint":182,"contacts":183},"Oxford University Hospital NHS Foundation Trust","Oxford",{"type":106,"coordinates":179},[180,181],-1.25596,51.75222,{"lat":181,"lon":180},[184],{"name":185,"role":91,"phone":114,"phoneExt":66,"email":186},"Stuart Winter","stuart.winter@ouh.nhs.uk",{"facility":188,"status":101,"city":189,"state":66,"zip":66,"country":103,"countryCode":104,"cosmosGeoPoint":190,"geoPoint":194,"contacts":195},"Poole Hospital, University Hospitals Dorset","Poole",{"type":106,"coordinates":191},[192,193],-1.98458,50.71429,{"lat":193,"lon":192},[196],{"name":197,"role":91,"phone":114,"phoneExt":66,"email":198},"Emma King","emma.king@uhd.nhs.uk",{"facility":200,"status":201,"city":202,"state":66,"zip":66,"country":103,"countryCode":104,"cosmosGeoPoint":203,"geoPoint":207,"contacts":66},"South Tyneside and Sunderland NHS Foundation Trust","COMPLETED","Sunderland",{"type":106,"coordinates":204},[205,206],-1.38222,54.90465,{"lat":206,"lon":205},{"type":209,"investigatorFullName":66,"investigatorTitle":66,"investigatorAffiliation":66,"oldNameTitle":66,"oldOrganization":66},"SPONSOR","100501412",false,"NCT05808920","The RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Carcinoma of the Head and Neck","RESCUE","Inclusion Criteria:\n\n1. Aged over 18\n2. Previous H\\&N SCC treated with radiotherapy with or without chemotherapy\n3. Local or regionally recurrent, residual, or new primary SCC of the oropharynx, oral cavity, larynx, and hypopharynx\n4. Ability to give informed consent for biological sample collection (molecular analysis study only)\n\nExclusion Criteria:\n\n1. Nasopharyngeal and cutaneous SCC of the H\\&N\n2. Thyroid, salivary gland, and non-squamous cell H\\&N cancers\n3. Presence of distant metastasis (M1) or surgically inoperable T4b tumours","ALL","18 Years",{"count":219,"type":220},400,"ESTIMATED","OBSERVATIONAL","The RESCUE study is a combined retrospective and prospective multicentre cohort study investigating the survival and functional outcomes in patients undergoing salvage surgery for recurrent, residual, and new primary head and neck squamous cell carcinoma (SCC).\n\nAdditionally, the RESCUE study will contain an exploratory molecular analysis of consenting patients to assess the relationship between cancer genomics, previous radiotherapy, and recurrence in head and neck cancer.",[224],"Head and Neck Cancer","2026-02-09",{"date":227,"type":228},"2026-02-12","ACTUAL",{"date":230,"type":228},"2023-09-08",{"date":232,"type":220},"2029-04-30",{"name":5,"class":6},9]